PATRITUMAB
UNII 86780VJI1Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Patritumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 86780VJI1Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1262787-83-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

86780VJI1Q

CAS Registry Number

1262787-83-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PATRITUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C78853

National Cancer Institute reference terminology for clinical and research data.

INN ID

9549

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-232

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Patritumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PATRITUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEUREGULIN RECEPTOR HER3) (HUMAN MONOCLONAL U3-1287 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL U3-1287 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-447) (HOMO SAPIENS VH (IGHV4-34*01 (99.00%) -(IGHD)-IGHJ2*01) (8.7.11) (1-117) -IGHG1*03 (118-447)), (220-220')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-220') (HOMO SAPIENS V-KAPPA (IGKV4-1*01 (95.00%) -IGKJ1*01) (12.3.9) (1'-113') - IGKC*01 (114'-220')); (226-226'':229-229'')-BISDISULFIDE DIMER

PATRITUMAB [INN]

PATRITUMAB [USAN]

PATRITUMAB [WHO-DD]